ICU sedation, delirium & recovery
Survival of Critically Ill COVID-19 Patients in Sweden During the First Two and a Half Years of the Pandemic*
Authors' conclusion
In this nationwide Swedish cohort covering over two and a half years of the pandemic, ICU survival rates changed over time. Older age was a strong predictor across all periods. Furthermore, most other mortality predictors remained consistent across different variant periods.
Study context
- Population
- Adult (≥18 yr) COVID-19 ICU patients, Swedish Intensive Care Register, March 6, 2020–December 31, 2022
- Participants
- 8,975 participants
- Outcome
- Survival probability and predictors of COVID-19 death
Methodological detailsnationwide, register-based
- Nationwide
- Register-based
Main finding
As reported in the abstract
Death
Adjusted hazard ratio (95% CI)
Foreign-born
0.87(0.80–0.95)
Booster vaccine
0.74(0.65–0.84)
Steroids
0.91(0.84–0.98)
- Died, of 8975 patients
- 2927 (32.6%)
- aHR of death significantly higher for men, age 40+ yr, low income, chronic heart, lung, renal disease, impaired immune disease, stroke, cancer, invasive or noninvasive respiratory support, septic shock, organ failures
- P < 0.05
Observational data: associations, not effects.
Original publication
Survival of Critically Ill COVID-19 Patients in Sweden During the First Two and a Half Years of the Pandemic*. Crit Care Med. Published 28 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →